MAXIMIZING ONCOLOGY ANALYSIS WITH BUILT-IN KRAS ASSAY COMPANIES AND RAS ASSAYS

while in the quickly evolving KRAS assay services discipline of oncology study, precise and economical mutation screening is very important for establishing targeted therapies. The KRAS companies System plays a pivotal purpose With this landscape by presenting complete options for KRAS mutation profiling and Investigation. KRAS mutations, found in